Revenue

The hormone optimization leader's stock tumbles after Q2 results show a net loss and declining revenue, revealing the prolonged impact of its January recall.

The clean-living brand's revenue is down, but profits and confidence are soaring. A deep dive into how strategic cuts are building a more durable company.

The agentic customer platform posts 20% revenue growth and a return to profitability, yet a softer forecast reveals underlying market pressures.

With a new $345 genome and major clinical wins, PacBio pushes boundaries. But can its strategic restructuring and bold R&D overcome mounting financial losses?

Cytek Biosciences raises 2026 guidance on new tech, but rising costs and a wider net loss have investors questioning its path to sustainable profit.

KORU Medical posts record profits, but the real story is its strategic overhaul. We dissect its oncology pivot and digital tech bet for long-term value.

LegalZoom posts strong Q2 profits and subscription growth but lowers revenue guidance, signaling a pivotal battle against shifting AI-driven customer discovery.

A $12 million solar write-down pushed NACCO Industries to a net loss, but underneath, its core mining businesses are thriving, revealing a strategic pivot.

As Cisco prepares its Q4 results, all eyes are on its multi-billion dollar AI strategy. Will the numbers validate its pivot to an AI-first future?

Record revenue and soaring profits are just the surface. A look at how Cognex's disciplined AI strategy and market diversification are building a resilient automation powerhouse.

Fidelity National Financial's Q2 earnings surpassed expectations, fueled by a record-performing Title segment and strategic AI investments in its infrastructure.

VIAVI Solutions smashes expectations with a 40% annual revenue jump, proving its diversification into datacenter and defense markets is paying off handsomely.

Thinkific's Q2 results reveal a company in deep transition, balancing heavy AI investment and a strategic upmarket push against the immediate need for profit.

Zillow's Q2 revenue soars 18%, but a deeper look reveals a complex reality: declining user traffic, a GAAP net loss, and a high-stakes antitrust battle.

GRAIL’s Galleri test shows stunning clinical results and sales growth, but staggering financial losses and a looming FDA review create a high-wire act for innovation.

The French digital services firm posts stellar Q2 results, driven by agentic AI. A deep dive into the strategy and execution behind the impressive numbers.

AGS's land-based hit, Bonus Spin Xtreme, is now online exclusively at BetRivers. Is this the move that makes online table games the next big jackpot frontier?

As the nation's fastest-growing beverage brand, 7 Brew's new app is more than a convenience; it's a strategic weapon for data, speed, and market dominance.

As John Deere preps for its Q3 earnings, all eyes are on whether its tech pivot and construction strength can offset a soft farm economy. We break it down.

As Flowers Foods preps its Q2 results amid a plummeting stock price, the bakery giant's strategic pivot towards health trends and fiscal discipline faces a critical test.